کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
877401 911024 2015 10 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Targeted delivery of paromomycin in murine infectious diseases through association to nano lipid systems
ترجمه فارسی عنوان
تحویل هدفمند از پارومومیسین در بیماری های عفونی موش از طریق ارتباط با سیستم های نانو لیپیدها
کلمات کلیدی
لیپوزوم ها، عفونت های داخل سلولی، مدل های موی، پارامومایسین
موضوعات مرتبط
مهندسی و علوم پایه سایر رشته های مهندسی مهندسی پزشکی
چکیده انگلیسی

Treatment of intracellular infections such as those caused by Mycobacterium spp. and Leishmania spp. is often hampered by limited access of drugs to infected cells. This is the case of paromomycin (PRM), an antibiotic with broad spectrum in vitro activity against protozoa and mycobacteria. Association of chemotherapeutics to liposomes is a worthy strategy to circumvent poor drug accessibility. Six different PRM liposomal formulations were produced, physicochemically characterized and biologically evaluated in a macrophagic cell line confirming their adequacy for in vivo studies. Biodistribution profiles of PRM liposomes revealed preferential targeting of the antibiotic to the liver, spleen and lungs, relative to free PRM, which translated into an enhanced therapeutic effect in murine models infected with Mycobacterium avium and Leishmania infantum and an absence of toxic effects. Our findings demonstrate the advantages of associating PRM to liposomes indicating their potential as an alternative therapeutic strategy for mycobacterial and parasite infections.From the Clinical EditorInfections caused by intracellular organisms such as Mycobacterium and Leishmania remain a significant problem worldwide. Although effective drugs are available, their actions are limited by access into the intracellular compartment. In this article, the authors developed different liposomal formulations as drug carriers of paromomycin and investigated their efficacy in a mouse model. The positive should provide another treatment option for these organisms in the near future.

Paromomycin encapsulated in liposomes constitutes an alternative therapeutic strategy for the treatment of mycobacterial and parasite infections as a result of an improved biodistribution profile and prolonged accumulation in infected organs (liver, white bars; spleen, black bars; lung gray bars).Figure optionsDownload high-quality image (72 K)Download as PowerPoint slide

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Nanomedicine: Nanotechnology, Biology and Medicine - Volume 11, Issue 7, October 2015, Pages 1851–1860
نویسندگان
, , , , , , , ,